Clinical Trial Update: Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial examining sequential Fruquintinib with Bevacizumab and FOLFIRI versus Bevacizumab plus FOLFIRI sequential Fruquintinib in metastatic colorectal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Weijian Guo | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN